mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.2 |
0.0002 |
mRNA |
GW843682X |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
mRNA |
HG-5-113-01 |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
0.0002 |
mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0003 |
mRNA |
Bleomycin |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0003 |
mRNA |
CCT018159 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
mRNA |
BX-795 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0004 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0005 |